Alkem laboratories schedules in-person meeting with institutional investor Citi India

Alkem Laboratories Limited, headquartered in Mumbai, India, issued an intimation on November 25, 2025, regarding a scheduled analyst / institutional investor meeting. The company will engage with Citi India Pharma & Healthcare Tour 2025.

The meeting is slated for November 28, 2025, and will be an in-person, one-on-one session held in Mumbai. This engagement falls under the purview of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also noted that the schedule is subject to change based on exigencies from the investor or the company.

The announcement was signed digitally by Manish Narang on November 25, 2025. Manish Narang holds the position of president – legal, company secretary & compliance officer at Alkem Laboratories Limited.